Ingrid Dijkgraaf Selected Research

CC Chemokines

10/2020

Structural characterization of anti-CCL5 activity of the tick salivary protein evasin-4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid Dijkgraaf Research Topics

Disease

19	Neoplasms (Cancer) 06/2021 - 11/2002
7	Inflammation (Inflammations) 01/2021 - 11/2011
5	Thrombosis (Thrombus) 08/2022 - 01/2021
4	Atherosclerosis 01/2021 - 01/2017
4	Neoplasm Metastasis (Metastasis) 10/2019 - 11/2006
2	Myocardial Infarction 01/2015 - 12/2014
2	Carcinoma (Carcinomatosis) 02/2007 - 08/2004
1	Tick-Borne Diseases (Tick-Borne Disease) 03/2023
1	Pancreatitis 01/2023
1	Pathologic Constriction (Stenosis) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Dermatitis 10/2019
1	Melanoma (Melanoma, Malignant) 10/2019
1	Acute Lung Injury 01/2017
1	Ischemia 10/2016
1	Infarction (Infarctions) 01/2015
1	Fibrosis (Cirrhosis) 12/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2013
1	Prostatic Neoplasms (Prostate Cancer) 06/2012
1	Infections 11/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2011
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2007

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 06/2021 - 11/2002
8	IntegrinsIBA 08/2022 - 08/2004
7	arginyl-glycyl-aspartic acidIBA 10/2019 - 11/2002
7	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2019 - 11/2002
6	Integrin beta3 (GPIIIa)IBA 12/2009 - 11/2002
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 11/2006
5	ChemokinesIBA 10/2020 - 01/2017
5	cyclic arginine-glycine-aspartic acid peptideIBA 10/2019 - 11/2006
4	Radioisotopes (Radionuclides)IBA 05/2010 - 08/2004
3	AnticoagulantsIBA 01/2023 - 01/2021
3	LigandsIBA 10/2020 - 12/2009
3	Integrin alphaVbeta3IBA 01/2009 - 11/2002
3	aspartic acid glycine arginineIBA 01/2007 - 08/2004
2	CollagenIBA 08/2022 - 01/2021
2	FibrinIBA 01/2022 - 01/2021
2	3-Tyr-octreotideIBA 06/2012 - 05/2010
2	Chemokine ReceptorsIBA 11/2011 - 11/2011
2	Extracellular Matrix ProteinsIBA 01/2009 - 11/2006
2	Peptide Receptors (Peptide Receptor)IBA 02/2007 - 08/2004
1	VaccinesIBA 03/2023
1	AntioxidantsIBA 01/2023
1	platelet membrane glycoprotein VIIBA 08/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2022
1	Epidermal Growth Factor (EGF)IBA 06/2021
1	nonaarginineIBA 06/2021
1	penetratinIBA 06/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Eptifibatide (Integrilin)FDA Link 01/2021
1	Dabigatran FDA Link 01/2021
1	disagreginIBA 01/2021
1	N(4)-oleylcytosine arabinosideIBA 01/2021
1	Vitamin K FDA Link 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	CC ChemokinesIBA 10/2020
1	Galectins (Galectin)IBA 01/2020
1	sharpinIBA 10/2019
1	Salivary Proteins and PeptidesIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Chemokine CXCL1IBA 10/2016
1	IsotopesIBA 01/2015
1	matrigelIBA 01/2015
1	salicylhydroxamic acid (SHAM)IBA 12/2014
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 05/2013
1	Leucine EnkephalinIBA 06/2012
1	Bombesin Receptors (Bombesin Receptor)IBA 06/2012
1	BombesinIBA 06/2012
1	Blood Proteins (Serum Proteins)IBA 11/2011
1	plerixafor FDA Link 11/2011
1	AntigensIBA 12/2009
1	AntibodiesIBA 12/2009
1	Fibronectins (Fibronectin)IBA 12/2009
1	Oxygen (Dioxygen)IBA 12/2009
1	TenascinIBA 12/2009
1	Matrix Metalloproteinases (MMPs)IBA 12/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009
1	Arginine (L-Arginine)FDA Link 01/2009
1	Aspartic Acid (Aspartate)FDA Link 01/2009
1	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2007
1	RadiopharmaceuticalsIBA 09/2007
1	Dendrimers (Dendrons)IBA 03/2007
1	Glutamic Acid (Glutamate)FDA Link 01/2007
1	Lysine (L-Lysine)FDA Link 01/2007
1	VitronectinIBA 11/2006
1	PeptoidsIBA 11/2006
1	PeptidomimeticsIBA 11/2006
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 11/2002
1	7- (2- bis(2- hydroxyethyl)aminoethyl)theophylline (G 111)IBA 11/2002

Therapy/Procedure

6	Therapeutics 01/2023 - 08/2004
2	Ligation 01/2022 - 01/2015
1	Aftercare (After-Treatment) 01/2023